Medtronic Recalls Disposable Heparin-Coated Device Line
This article was originally published in PharmAsia News
Medtronic announced it is recalling its disposable devices coated with Carmeda BioActive surface because they include heparin. The firm said it was exercising precaution in the wake of U.S. FDA advice based on an investigation of contaminated Chinese-produced heparin. Medtronic said it had no reports of problems with its Carmeda products, but it could rely on a separate line of disposable bypass-surgery products covered with trillium because they contain smaller amounts of heparin. (Click here for more
You may also be interested in...
AdvaMed’s VentConnect platform is expanding to support production of devices needed to treat COVID-19. Here’s what Eric Fanning, CEO of participating group the Aerospace Industries Association, said about the move.
Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.